MARC

Tag First Indicator Second Indicator Subfields
LEADER 00000cam a2200000Ia 4500
001 in00002000541
005 20220105141708.0
006 m d
007 cr cnu---unuuu
008 040319s2004 dcua sb 000 0 eng d
020 |a 0309527201 (electronic bk.) 
035 |a (OCoLC)ocm54770887 
040 |a N$T  |c N$T  |d OCLCQ  |d UtOrBLW 
049 |a IKMN 
050 1 4 |a RA776.75  |b .T45 2004eb 
060 1 4 |a WT 104  |b T3455 2004 
082 0 4 |a 612.6/8  |2 22 
245 0 0 |a Testosterone and aging :  |b clinical research directions /  |c Committee on Assessing the Need for Clinical Trials of Testosterone Replacement Therapy, Board on Health Sciences Policy ; Catharyn T. Liverman and Dan G. Blazer, editors. 
264 1 |a Washington, DC :  |b National Academies Press,  |c [2004] 
264 4 |c ©2004 
300 |a xvii, 219 pages :  |b illustrations ;  |c 23 cm. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references. 
505 0 |a INTRODUCTION -- Scope of this Report -- Aging and Hormonal Changes -- Testosterone, Human Development, and Health -- Measuring Testosterone Levels -- Testosterone Therapy -- Growing Use of Testosterone Therapy -- Clinical Trials -- TESTOSTERONE AND HEALTH OUTCOMES -- Changes in Endogenous Testosterone Levels with Aging -- Literature Review -- Bone -- Body Composition and Strength -- Physical Function -- Cognitive Function -- Mood and Depression -- Sexual Function -- Health-Related Quality of Life -- Cardiovascular and Hematologic Outcomes -- Prostate Outcomes -- Other Health Outcomes -- Multiple Outcomes -- FUTURE RESEARCH DIRECTIONS -- Strategy for Future Clinical Trials in Older Men -- Recommendations -- Initial Efficacy Trials in Older Men -- Protection of Research Participants: Safety and Ethical Issues -- Additional Areas of Research -- Need for Efficacy Studies in Older Men -- Clinical Studies in Middle-Aged Men. 
533 |a Electronic reproduction.  |b Boulder, Colo. :  |c NetLibrary,  |d 2004.  |n Available via World Wide Web.  |n Access may be limited to NetLibrary affiliated libraries. 
500 |a Electronic resource. 
650 0 |a Longevity.  |0 http://id.loc.gov/authorities/subjects/sh85078286 
650 0 |a Aging  |x Prevention.  |0 http://id.loc.gov/authorities/subjects/sh98002534 
650 0 |a Testosterone  |x Physiological effect. 
650 1 2 |a Aging  |x drug effects.  |0 https://id.nlm.nih.gov/mesh/D000375Q000187 
650 2 2 |a Testosterone  |x physiology.  |0 https://id.nlm.nih.gov/mesh/D013739Q000502 
650 2 2 |a Testosterone  |x therapeutic use.  |0 https://id.nlm.nih.gov/mesh/D013739Q000627 
655 7 |a Electronic books.  |2 local 
700 1 |a Liverman, Catharyn T.  |0 http://id.loc.gov/authorities/names/n95019366 
700 1 |a Blazer, Dan G.,  |c II  |q (Dan German),  |d 1944-  |0 http://id.loc.gov/authorities/names/n85074849 
710 2 |a National Research Council (U.S.).  |b Committee on Assessing the Need for Clinical Trials of Testosterone Replacement Therapy.  |0 http://id.loc.gov/authorities/names/n2003131040 
710 2 |a NetLibrary, Inc.  |0 http://id.loc.gov/authorities/names/no99080690 
776 1 |c Original  |z 0309090636  |w (DLC) 2003026323  |w (OCoLC)53840363 
856 4 1 |u https://proxy.library.tamu.edu/login?url=http://www.netLibrary.com/urlapi.asp?action=summary&v=1&bookid=106780  |z Connect to the full text of this electronic book  |t 0 
994 |a 92  |b IKM 
999 |a MARS 
999 f f |s 7be7c9a6-b26f-3ec7-8091-8c642571cc0d  |i 09b497fe-c3a6-3cca-ab87-0271574d1d4c  |t 0 
952 f f |a Texas A&M University  |b College Station  |c Electronic Resources  |d Available Online  |t 0  |e RA776.75 .T45 2004eb  |h Library of Congress classification 
998 f f |a RA776.75 .T45 2004eb  |t 0  |l Available Online